COMPARATIVE ALBENDAZOLE SULPHOXIDE PHARMACOKINETICS AFTER SINGLE ORAL ADMINISTRATION OF THREE DIFFERENT FORMULATIONS IN DOGS

DIB A.; PALMA S.; SUÁREZ G.; FARÍAS C.; CABRERA A.; CASTRO S.; ALLEMANDI D.; MORENO L.; SÁNCHEZ BRUNI S.; LANUSSE C.

Rosario

Congreso; Congreso de la Sociedad Argentina de Farmacología Experimental. SAFE 2009; 2009

New therapeutics alternatives using Benzimidazole compounds are being studied to improve posology and antiparasite efficacy. The aim of this work was to compare plasma pharmacokinetics (PK) profiles of three different oral Albendazole (ABZ)-based formulations in dogs. Nine animals were randomly divided into three groups and two phases (incomplete block design).